Los Angeles Biotechnology Network
Advertise With Biotech Networks
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ September 28, 2023 ] STRIKE – RNs and Almost All Health Care Staff to Strike St. Francis Medical Center 10/9 – 10/13 Los Angeles Biotech News
  • [ September 28, 2023 ] Medical Laboratory Scientist (Generalist) – Clinical Laboratory – VIR Consultant LLC – Santa Monica, CA Los Angeles Biotech Jobs
  • [ September 28, 2023 ] TAE Life Sciences Celebrates Collaboration Milestones and Unveils Alphabeam for in-hospital BNCT at ASTRO 2023 Annual Meeting Los Angeles Biotech News
  • [ September 28, 2023 ] Alfred Mann Foundation Rebrands as huMannity Medtec, Unveiling a Bold, Future-Focused Identity Los Angeles Biotech News
  • [ September 28, 2023 ] Medical Laboratory Scientist – VIR Healthway – Santa Monica, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsAmgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers

Amgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers

March 30, 2021 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Amgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers

Amgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers
aalidrus
Tue, 03/30/2021 – 17:07

Previous

Going head-to-head with Merck on I/O, Genentech vets raise fresh round and enter clinic

Next

ChromaDex and the Citrin Foundation Announce Global Research Collaboration Exploring Citrin Deficiency

Follow/Subscribe

Advertise With Biotech Networks
POST A JOB
Tweets by LABioNetwork
Advertise With Biotech Networks

Copyright © 2023 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered